These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 21781625)
1. Support needed to involve psoriasis patients in treatment decisions: survey of dermatologists. Tan J; Stacey D; Barankin B; Bissonnette R; Gulliver W; Lui H; Shear N; Bhatti S J Cutan Med Surg; 2011; 15(4):192-200. PubMed ID: 21781625 [TBL] [Abstract][Full Text] [Related]
2. Treatment decision needs of psoriasis patients: cross-sectional survey. Tan J; Stacey D; Fung K; Barankin B; Bissonnette R; Gulliver W; Lui H; Shear N; Jackson C; Zhang X J Cutan Med Surg; 2010; 14(5):233-9. PubMed ID: 20868620 [TBL] [Abstract][Full Text] [Related]
3. The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians. van der Kraaij GE; Vermeulen FM; Smeets PMG; Smets EMA; Spuls PI J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2574-2583. PubMed ID: 32163645 [TBL] [Abstract][Full Text] [Related]
4. Dermatologists' views and opinions about photo(chemo)therapy and conventional systemic psoriasis therapies: results from a Belgian survey. Nijsten T; Lambert J Dermatology; 2006; 213(2):123-33. PubMed ID: 16902289 [TBL] [Abstract][Full Text] [Related]
5. Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations. Uhlenhake EE; Kurkowski D; Feldman SR J Dermatolog Treat; 2010 Jan; 21(1):6-12. PubMed ID: 19579071 [TBL] [Abstract][Full Text] [Related]
6. Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. Renzi C; Di Pietro C; Gisondi P; Chinni LM; Fazio M; Ianni A; Tabolli S Acta Derm Venereol; 2006; 86(6):528-34. PubMed ID: 17106601 [TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists. Wakkee M; Lugtenberg M; Spuls PI; de Jong EM; Thio HB; Westert GP; Nijsten T Br J Dermatol; 2008 Aug; 159(2):426-32. PubMed ID: 18616791 [TBL] [Abstract][Full Text] [Related]
8. Shared treatment decision making: what does it mean to physicians? Charles CA; Whelan T; Gafni A; Willan A; Farrell S J Clin Oncol; 2003 Mar; 21(5):932-6. PubMed ID: 12610196 [TBL] [Abstract][Full Text] [Related]
9. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists. Ashcroft DM; Seston E; Griffiths CE Br J Dermatol; 2006 Dec; 155(6):1236-41. PubMed ID: 17107395 [TBL] [Abstract][Full Text] [Related]
10. Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey. Yeroushalmi S; Nelson K; Sparks A; Friedman A Complement Ther Med; 2020 Dec; 55():102552. PubMed ID: 33220620 [TBL] [Abstract][Full Text] [Related]
11. Family and physician influence on asthma research participation decisions for adolescents: the effects of adolescent gender and research risk. Brody JL; Scherer DG; Annett RD; Turner C; Dalen J Pediatrics; 2006 Aug; 118(2):e356-62. PubMed ID: 16882778 [TBL] [Abstract][Full Text] [Related]
12. Guideline-compliant prescription of biologicals and possible barriers in dermatological practices in Bavaria. Schielein MC; Tizek L; Rotter M; Konstantinow A; Biedermann T; Zink A J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):978-984. PubMed ID: 29356181 [TBL] [Abstract][Full Text] [Related]
13. Supporting patients facing difficult health care decisions: use of the Ottawa Decision Support Framework. Légaré F; O'Connor AC; Graham I; Saucier D; Côté L; Cauchon M; Paré L Can Fam Physician; 2006 Apr; 52(4):476-7. PubMed ID: 17327891 [TBL] [Abstract][Full Text] [Related]
14. [Opinion of Spanish dermatologists regarding the use of biologic therapy in patients with moderate to severe psoriasis]. Ara M; Pérez A; Ferrando J Actas Dermosifiliogr; 2011 Nov; 102(9):706-16. PubMed ID: 21600532 [TBL] [Abstract][Full Text] [Related]
15. Expert report on psoriasis: Spanish dermatologists' opinions on the use of biologic agents to manage moderate to severe psoriasis in adults. Puig L; de la Cueva P; Linares M; Suarez J; Velasco M; Vidal D; Zulaica A; García-Calvo C Actas Dermosifiliogr; 2013 Jun; 104(5):400-8. PubMed ID: 23669590 [TBL] [Abstract][Full Text] [Related]
16. Development of Patient Decision Aids for Plaque Psoriasis and Acne. Cameron M; Tan J; McLellan C; O'Neil AI; Reed A; Henderin C; Dellavalle RP; Boyal S Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261566 [TBL] [Abstract][Full Text] [Related]
17. Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey. Gooderham M; Papp K; Albrecht L; Grewal P; Gaudreau AJ J Drugs Dermatol; 2021 Feb; 20(2):126-132. PubMed ID: 33538558 [TBL] [Abstract][Full Text] [Related]
18. Psoriasis treatment patterns of dermatologists in northeast Ohio. Grozdev I; Cao L; Kavlick K; Brodell RT; Mostow EN; Korman NJ J Cutan Med Surg; 2011; 15(3):157-61. PubMed ID: 21561584 [TBL] [Abstract][Full Text] [Related]
19. Satisfaction with treatment among patients with psoriasis: a web-based survey study. van Cranenburgh OD; de Korte J; Sprangers MA; de Rie MA; Smets EM Br J Dermatol; 2013 Aug; 169(2):398-405. PubMed ID: 23565643 [TBL] [Abstract][Full Text] [Related]
20. A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus. Strohal R; Prinz JC; Girolomoni G; Nast A J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2390-8. PubMed ID: 26370908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]